RecruitingPhase 1NCT06258304
A Dose Escalation and Expansion Study of GIGA-564 in Participants With Locally Advanced or Metastatic Solid Tumor Malignancies
Sponsor: GigaGen, Inc.
Bethesda, MD
1 recruiting type 1 diabetes studies with a site in Bethesda, MD.
Sponsor: GigaGen, Inc.
Bethesda, MD
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.